2,104
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Ticagrelor recommended over clopidogrel in STEMI patients

, &
Pages 983-985 | Received 24 May 2016, Accepted 20 Jun 2016, Published online: 01 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christos Pappas, John Lekakis & Dimitrios Alexopoulos. (2016) Response to: Ticagrelor recommended over clopidogrel, only in clinical trials or also in a real-world practice?. Expert Review of Cardiovascular Therapy 14:10, pages 1105-1105.
Read now

Articles from other publishers (2)

Benjamin J. Curry, A.O.F. Sem Rikken, C. Michael Gibson, Christopher B. Granger, Arnoud W.J. van ‘t Hof, Jurriën M. ten Berg & Lisa K. Jennings. (2023) Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation. Journal of Thrombosis and Thrombolysis.
Crossref
Dong-Tao Li, Shun-Bao Li, Jian-Yong Zheng, Hai-hong Tang, Yi-Gang Qiu, Ning Xue & Yi Cao. (2019) Analysis of ticagrelor’s cardio-protective effects on patients with ST-segment elevation acute coronary syndrome accompanied with diabetes. Open Medicine 14:1, pages 234-240.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.